Capvaxive was approved in 2024 for the prevention of invasive pneumococcal disease and pneumococcal pneumonia caused by Streptococcus pneumoniae in adults.

David Kuter, MD, DPhil discusses Wayrilz™ (rilzabrutinib), a new FDA-approved treatment for persistent or chronic immune thrombocytopenia (ITP). Dr Kuter ...

Study results suggest that “clinicians may be unaware of important clinical trial limitations identified by the FDA when making prescribing decisions,” researchers wrote.

The American Academy of Family Physicians (AAFP) has released its fall immunization recommendations for 3 common respiratory viruses. The guidance provides evidence-based vaccine recommendations for ...

HealthDay News — The US Food and Drug Administration released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to prescription opioid misuse.

(HealthDay News) — DermaRite Industries has expanded a voluntary recall of several over-the-counter creams, soaps and ...

The Food and Drug Administration (FDA) has approved Koselugo (selumetinib) oral granules and capsules for pediatric patients aged 1 year and older with neurofibromatosis type 1 (NF1) who have ...

Written by researchers for the US Department of Health and Human Services (HHS), the Alcohol Intake and Health Study warned that even one drink a day boosts the risk of liver cirrhosis, oral and ...

Chagas disease — a potentially serious illness spread by an insect called the “kissing bug” — may be establishing itself in the US, according to a new US Centers for Disease Control and Prevention ...

The committee found strong evidence that glucagon-like peptide-1 (GLP-1) receptor agonists benefit people with type 2 diabetes, particularly those with heart or kidney disease, by improving glucose ...

In August, the Food and Drug Administration had approved Pfizer-BioNTech’s new COVID-19 vaccine based on preclinical data.

HealthDay News — A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder (GAD), according to a study ...